Post-Market Surveillance Services

Systematic, proactive monitoring of medical devices throughout the commercial lifecycle — transforming real-world field data into regulatory-grade safety intelligence

ABOUT CARELYFT PMS SERVICES

CareLyft's Post-Market Surveillance (PMS) Services provide medical device manufacturers with a structured, end-to-end capability to monitor, evaluate, and act on real-world device performance data. With deep regulatory expertise across 40+ markets, CareLyft ensures your devices remain safe, effective, and compliant — from first commercialisation through their entire operational lifetime.

Our PMS team combines experienced regulatory affairs professionals, clinical specialists, and complaint management experts to deliver a seamless, audit-ready surveillance programme — fully aligned with EU MDR 2017/745, EU IVDR 2017/746, 21 CFR Part 803/806, ISO 13485, and applicable global vigilance frameworks.

CareLyft's PMS programme is built on eight integrated service pillars, each designed to address a critical dimension of post-market oversight. Our services can be engaged individually or as a fully managed, end-to- end PMS programme tailored to your device portfolio and regulatory obligations.

01. Complaints Intake, Evaluation, Investigation & Closure

A fully managed complaint handling programme covering the complete complaint lifecycle — from first receipt through thorough investigation to formal closure — in compliance with ISO 13485 Clause 8.2.2, 21 CFR Part 820.198, and MDR Article 87 requirements.

  • Multi-channel complaint intake: phone, email, field service reports, and eQMS portals
  • Initial triage and reportability assessment — MDR / MDV / voluntary report determination
  • Technical and clinical complaint investigation, including device analysis coordination
  • Root cause analysis (RCA) and risk-benefit evaluation for complaint events
  • Regulatory reporting decision documentation and justification records
  • Complaint trending, signal detection, and escalation to CAPA where required
  • Complaint closure with comprehensive investigation summary reports
02. Vigilance Reporting

End-to-end incident reporting across global markets — timely, accurate, and fully compliant submissions to competent authorities.

  • SI & FSCA reporting under EU MDR/IVDR
  • FDA MDR submissions (21 CFR Part 803)
  • Health Canada MPR & TGA/PMDA adverse event reporting
  • Competent Authority query management & supplemental submissions
  • Vigilance report authoring, submission & tracking
  • PSUR & SSCP preparation and support
03. UDI & Device (Tracking) Traceability Management

Robust tracking systems maintaining product traceability across the supply chain and end-use environment — aligned with UDI and post-market requirements.

  • Unique Device Identification (UDI) system setup and compliance — EU EUDAMED, FDA GUDID, and global databases
  • Lot/batch and serial number traceability across distribution tiers
  • Implant & high-risk device tracking programme management
  • Device registry enrolment & ongoing maintenance
  • Track & trace protocols for mandatory tracking obligations
  • Distribution record review & field inventory reconciliation
04. Medical & Technical Inquiry Management

Structured handling of inquiries from HCPs, patients, and distributors — accurate, compliant responses that support safe device use.

  • Inquiry intake, logging, and classifications
  • Clinical & technical response authoring by qualified professionals
  • Review & approval workflows aligned with regulatory standards
  • Off-label use inquiry management & documentation
  • Trending analysis to identify recurring safety or usability signals
  • Response library & medical information database maintenance
  • Escalation pathways for adverse events or safety concern
05. Device Recall and Return Management

End-to-end support for device recalls, removals, and market withdrawals — swift, compliant action to protect patient safety and regulatory standing.

  • Recall classification & regulatory notification preparation (Class I/II/III, FSN)
  • Recall strategy development & effectiveness check (REC) design
  • Customer & distributor notification authoring and dispatch
  • Returned device logging & disposition coordination
  • Regulatory agency correspondence & progress reporting
  • Post-recall documentation & closure submissions
  • Mock recall readiness exercises & procedure development
06. PMS Reporting (PMSR, PSUR, PMCF)
  • Post-Market Surveillance Reports (PMSR)
  • Periodic Safety Update Reports (PSUR)
  • Post-Market Clinical Follow-up (PMCF) reports
  • Benefit-risk evaluation and clinical data analysis
  • Regulatory-compliant documentation
07. Post Market / Device Technical Support

Specialised support bridging field performance, complaint investigations, and regulatory documentation — backed by deep device knowledge.

  • Failure analysis & returned device evaluation
  • Post-market change impact reviews (design & labelling)
  • CER, PMCF, and PMPF updates
  • Usability/human factors post-market studies
  • SaMD software & cybersecurity assessments
  • Regulatory technical file updates from post-market findings
  • Expert technical review for product liability
08. Health Hazard Evaluation

Rigorous, structured Health Hazard Evaluation (HHE) to assess the clinical impact of device defects, failures, or non-conformities — providing the evidentiary basis for informed reportability and recall decisions.

  • HHE initiation triggered by complaints, audit findings, CAPA, or vigilance events
  • Clinical risk assessment using ISO 14971 risk management principles
  • Reportability determination: serious injury, death, or malfunction assessment
  • HHE documentation to regulatory submission standard (FDA, MDR, Health Canada)
  • Medical and clinical expert review and sign-off coordination
  • HHE outcomes fed back into risk management files and PMS plans

REGULATORY FRAMEWORKS SUPPORTED

CareLyft's PMS team operates across the following regulatory frameworks and standards:

EU MDR 2017/745 EU IVDR 2017/746 ISO 13485:2016
21 CFR Part 803 (FDA MDR) 21 CFR Part 806 (Recalls) 21 CFR Part 820 (QSR)
ISO 14971:2019 MEDDEV 2.12/1 Rev 8 Health Canada MDR
TGA (Australia) MHLW / PMDA (Japan) MDSAP

WHY CHOOSE CARELYFT FOR PMS

ISO 13485-certified PMS operations with End-to-End PMS lifecycle management

Experienced Regulatory professionals with strong regulatory expertise and domain knowledge

Audit-ready documentation and traceability at every step

Seamless eQMS and complaint system integration

Scalable solutions tailored to your business needs

Multi-market simultaneous vigilance submissions

Scalable — from single-product to full portfolio management

Timely submissions and audit-ready processes

Transparent KPI reporting and real-time dashboards

High-quality, compliant documentation and reporting

DEVICE TYPES SUPPORTED

CareLyft's PMS Services support the full spectrum of medical device categories:

Software as a Medical Device (SaMD)

Consumer & Home Healthcare Devices

Wearables & Connected Technologies

Drug-Device Combination Products

In Vitro Diagnostic (IVD) Devices

Capital & Implantable Devices